JP2021530988A5 - - Google Patents

Info

Publication number
JP2021530988A5
JP2021530988A5 JP2021500866A JP2021500866A JP2021530988A5 JP 2021530988 A5 JP2021530988 A5 JP 2021530988A5 JP 2021500866 A JP2021500866 A JP 2021500866A JP 2021500866 A JP2021500866 A JP 2021500866A JP 2021530988 A5 JP2021530988 A5 JP 2021530988A5
Authority
JP
Japan
Prior art keywords
cas9
combination according
mrna
sequence
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021500866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021530988A (ja
JP7590952B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/041551 external-priority patent/WO2020014577A1/en
Publication of JP2021530988A publication Critical patent/JP2021530988A/ja
Publication of JP2021530988A5 publication Critical patent/JP2021530988A5/ja
Priority to JP2024135748A priority Critical patent/JP2024164090A/ja
Application granted granted Critical
Publication of JP7590952B2 publication Critical patent/JP7590952B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021500866A 2018-07-13 2019-07-12 遺伝子編集の高特異性を達成する方法 Active JP7590952B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024135748A JP2024164090A (ja) 2018-07-13 2024-08-15 遺伝子編集の高特異性を達成する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862697955P 2018-07-13 2018-07-13
US62/697,955 2018-07-13
PCT/US2019/041551 WO2020014577A1 (en) 2018-07-13 2019-07-12 Methods of achieving high specificity of genome editing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024135748A Division JP2024164090A (ja) 2018-07-13 2024-08-15 遺伝子編集の高特異性を達成する方法

Publications (3)

Publication Number Publication Date
JP2021530988A JP2021530988A (ja) 2021-11-18
JP2021530988A5 true JP2021530988A5 (cg-RX-API-DMAC7.html) 2022-07-19
JP7590952B2 JP7590952B2 (ja) 2024-11-27

Family

ID=69141767

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021500866A Active JP7590952B2 (ja) 2018-07-13 2019-07-12 遺伝子編集の高特異性を達成する方法
JP2024135748A Pending JP2024164090A (ja) 2018-07-13 2024-08-15 遺伝子編集の高特異性を達成する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024135748A Pending JP2024164090A (ja) 2018-07-13 2024-08-15 遺伝子編集の高特異性を達成する方法

Country Status (7)

Country Link
US (1) US20220195403A1 (cg-RX-API-DMAC7.html)
EP (1) EP3820503A4 (cg-RX-API-DMAC7.html)
JP (2) JP7590952B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210031482A (cg-RX-API-DMAC7.html)
CA (1) CA3106162A1 (cg-RX-API-DMAC7.html)
TW (1) TW202023605A (cg-RX-API-DMAC7.html)
WO (1) WO2020014577A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
EP3652312A1 (en) 2017-07-14 2020-05-20 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
US12521451B2 (en) 2019-11-08 2026-01-13 Regeneron Pharmaceuticals, Inc. CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy
EP4426828A1 (en) 2021-11-01 2024-09-11 Tome Biosciences, Inc. Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo
US20250057980A1 (en) 2021-12-22 2025-02-20 Tome Biosciences, Inc. Co-Delivery of a Gene Editor Construct and a Donor Template
CA3254504A1 (en) * 2022-03-04 2023-09-07 Epigenic Therapeutics Pte. Ltd. GENOME COMPOSITION AND EDITING METHODS
WO2023205744A1 (en) 2022-04-20 2023-10-26 Tome Biosciences, Inc. Programmable gene insertion compositions
WO2023215831A1 (en) 2022-05-04 2023-11-09 Tome Biosciences, Inc. Guide rna compositions for programmable gene insertion
WO2023225670A2 (en) 2022-05-20 2023-11-23 Tome Biosciences, Inc. Ex vivo programmable gene insertion
WO2024020587A2 (en) 2022-07-22 2024-01-25 Tome Biosciences, Inc. Pleiopluripotent stem cell programmable gene insertion
CN115312122B (zh) * 2022-10-12 2022-12-16 之江实验室 一种CRISPR-Cas酶可突变位点推荐方法和装置
WO2024138194A1 (en) 2022-12-22 2024-06-27 Tome Biosciences, Inc. Platforms, compositions, and methods for in vivo programmable gene insertion
WO2024234006A1 (en) 2023-05-11 2024-11-14 Tome Biosciences, Inc. Systems, compositions, and methods for targeting liver sinusodial endothelial cells (lsecs)
JP2026523341A (ja) 2023-05-15 2026-07-14 エヌクロマ・バイオ,インコーポレーテッド Hbv遺伝子発現のエピジェネティック調節のための組成物および方法
WO2025050069A1 (en) 2023-09-01 2025-03-06 Tome Biosciences, Inc. Programmable gene insertion using engineered integration enzymes
WO2025224107A1 (en) 2024-04-22 2025-10-30 Basecamp Research Ltd Method and compositions for detecting off-target editing
WO2025224182A2 (en) 2024-04-23 2025-10-30 Basecamp Research Ltd Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9862926B2 (en) * 2011-06-27 2018-01-09 Cellscript, Llc. Inhibition of innate immune response
US9234213B2 (en) * 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
WO2014204725A1 (en) * 2013-06-17 2014-12-24 The Broad Institute Inc. Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
PL3019619T3 (pl) * 2013-07-11 2022-01-10 Modernatx, Inc. Kompozycje zawierające syntetyczne polinkleotydy kodujące białka powiązane z crispr i syntetyczne sgrna oraz sposoby ich stosowania
US9340799B2 (en) * 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
CA2969619A1 (en) * 2014-12-03 2016-06-09 Agilent Technologies, Inc. Guide rna with chemical modifications
US10676499B2 (en) * 2014-12-16 2020-06-09 Novartis Ag 3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
CN104611368B (zh) * 2015-01-15 2018-05-25 中国科学院广州生物医药与健康研究院 重组后不产生移码突变的载体、在爪蛙基因组中进行基因定点敲入的方法及应用
EP4019635A1 (en) * 2015-03-25 2022-06-29 Editas Medicine, Inc. Crispr/cas-related methods, compositions and components
US10188750B1 (en) * 2015-10-23 2019-01-29 University Of South Florida Self-replicating cell selective gene delivery compositions, methods, and uses thereof
EP3426715A1 (en) * 2016-03-12 2019-01-16 The Regents of the University of California Biodegradable vectors for efficient rna delivery
CN118460529A (zh) * 2016-12-20 2024-08-09 百时美施贵宝公司 提高细胞基因组中同源定向修复(hdr)效率的方法

Similar Documents

Publication Publication Date Title
US20240247262A1 (en) Crispr/cas system and method for genome editing and modulating transcription
US20230091847A1 (en) Compositions and methods for improving homogeneity of dna generated using a crispr/cas9 cleavage system
US11225649B2 (en) Engineered nucleic-acid targeting nucleic acids
JP6960951B2 (ja) 配列操作のための系、方法および最適化ガイド組成物のエンジニアリング
JP2021118726A5 (cg-RX-API-DMAC7.html)
AU2020262371B2 (en) Nucleic acid constructs and methods for their manufacture
US12065667B2 (en) Modified Cpf1 MRNA, modified guide RNA, and uses thereof
US12612612B2 (en) Methods for exon skipping and gene knockout using base editors
US9868962B2 (en) CRISPR hybrid DNA/RNA polynucleotides and methods of use
CN111836894B (zh) 用于使用CRISPR/Cpf1系统进行基因组编辑的组合物及其用途
US10526590B2 (en) Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination
EP3178935B1 (en) Genome editing using campylobacter jejuni crispr/cas system-derived rgen
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
BR112020026246A2 (pt) composições, sistemas e métodos de amplificação com base em nickase dupla crispr
JP7762651B2 (ja) 修飾二重鎖ドナー鋳型
JP2024533448A (ja) 化学修飾を有するガイドrnaを使用する方法
CN104560995A (zh) 一对特异识别猪H11位点的sgRNA及其编码DNA和应用
WO2023169482A1 (en) Modified crispr-based gene editing system and methods of use
EP4230737A1 (en) Novel enhanced base editing or revising fusion protein and use thereof
JP2023542962A (ja) 新規の改良された塩基編集または編集用融合タンパク質およびその用途
KR20230016751A (ko) 염기 편집기 및 이의 용도
Ge et al. Synergistic engineering of Casδ nuclease for robust genome editing
CN116004719A (zh) 一种减少CRISPRCas9脱靶效应的方法
HK40116631A (zh) 修饰的基於crispr的基因编辑系统及其使用方法